logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. AZ Sint-Jan Brugge AV

+3250452111
info@azsintjan.be
Source: Site record.
https://www.azsintjan.be

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

AZ Sint-Jan Brugge AV is an autonomous healthcare institution where everyone is welcome, regardless of social background or religious beliefs. For this reason, the hospital deliberately applies only the officially agreed healthcare rates.Its 258 physicians and 3,462 other employees are committed to providing innovative, high-quality referral care for everyone. Its two campuses, Sint-Jan and SFX, together form the second-largest hospital in West Flanders.AZ Sint-Jan Brugge AV is also a leading referral hospital in the region and, for certain areas of expertise, serves patients from well beyond the region.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
55Total Trials
Source: Trial-derived.
9Recruiting Trials
Source: Trial-derived.
11Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
96Unique Conditions
Source: Trial-derived.
65Unique Sponsors

Conditions

Source: Trial-derived. Atrial Fibrillation (4)Source: Trial-derived. Myelodysplastic Syndromes (3)Source: Trial-derived. Myelofibrosis (3)Source: Trial-derived. Primary Myelofibrosis (3)Source: Trial-derived. Psoriasis Vulgaris (3)Source: Trial-derived. Myocardial Infarction (2)Source: Trial-derived. Pneumococcal Infections (2)Source: Trial-derived. Post Essential Thrombocythemia Myelofibrosis (2)

Sponsors

Source: Trial-derived. AZ Sint-Jan AV (6)Source: Trial-derived. The Lymphoma Academic Research Organisation (5)Source: Trial-derived. Celgene (4)Source: Trial-derived. Novo Nordisk A/S (4)Source: Trial-derived. Bayer (3)Source: Trial-derived. Incyte Corporation (3)Source: Trial-derived. KU Leuven (3)Source: Trial-derived. Stichting Hemato-Oncologie voor Volwassenen Nederland (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Lumbar puncture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. ESR1 mutation testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Neuropsychological assessment battery administration
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Visual acuity testing (Snellen chart)